虚拟中枢神经系统瘤委员会在加拿大青少年和年轻成年神经瘤网络中的轮回
Biren Dave1,2, Mikayla Machado3, Robert Siddaway4,5
1Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada.
JCO precision oncology
|October 30, 2025
概括
通过推向的药物和临床试验,以及减少放射治疗,国家多学科环节改善了对青少年和年轻成人 (AYA) 中枢神经系统瘤患者的护理. 这个倡议将对这个脆弱人群的治疗标准化.
科学领域:
- 神经瘤学神经瘤学
- 青少年和年轻人的医学 (AYA)
- 临床试验设计 临床试验设计
背景情况:
- 中枢神经系统 (CNS) 瘤是青少年和年轻成年人 (AYA;年龄15-39岁) 的主要死亡原因.
- 对于中枢神经系统瘤的AYA患者,通常缺乏标准化的治疗方案.
- 虚拟的多学科瘤板可以促进在不同地理位置的标准化护理.
研究的目的:
- 建立和评估全国多学科虚拟瘤董事会对加拿大中枢神经系统瘤AYA患者的影响.
- 改善和标准化在AYA人群中中枢神经系统瘤的管理.
- 评估集中分子审查在指导治疗决策中的作用.
主要方法:
- 从2021年11月到2024年6月实施全国多学科虚拟AYA中枢神经系统瘤委员会轮.
- 来自加拿大中心的185名中枢神经系统瘤AYA患者的介绍,其中包括138名质瘤患者.
- 使用TruSight技术对174个AYA中枢神经系统瘤进行了集中分子审查.
主要成果:
- 循环后,对临床试验和/或向药物的建议在质瘤患者中显著增加 (72.6%为儿科类型,45.9%为成人类型).
- 放射治疗建议减少了,之前放射治疗的44名患者中只有14人建议进一步放射治疗.
- 分子检查在很大一部分低度质瘤患者中发现了BRAF和FGFR1的改变 (融合:17.9%和7.4%;变异:7.4%和12.6%).
- 总体而言,68.9%的分析患者接受了治疗建议,代表了临床管理的变化.
结论:
- 全国一轮综合分子审查有效引导AYA中枢神经系统瘤患者进行向治疗和临床试验.
- 这种方法可以帮助推迟不必要的放射治疗,优化治疗策略.
- 该倡议证明了在加拿大标准化和改善对有中枢神经系统瘤的AYA患者的护理的成功模式.
相关概念视频
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Mouse Models of Cancer Study
6.4K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.4K
Disorders of the Nervous Tissue
2.5K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
2.5K


